Title:
MEDICAL COMPOSITION FOR PROMOTING FIBRINOLYSIS
Document Type and Number:
WIPO Patent Application WO/2016/104678
Kind Code:
A1
Abstract:
Provided is a novel medical composition capable of promoting fibrinolysis. The medical composition for promoting fibrinolysis contains edoxaban or a pharmaceutically acceptable salt thereof, or a hydrate of those. In addition to edoxaban or a pharmaceutically acceptable salt thereof, or a hydrate of those, the medical composition for promoting fibrinolysis further contains a TAFIa inhibitor.
Inventors:
FURUGORI TAKETOSHI (JP)
MORISHIMA YOSHIYUKI (JP)
MORISHIMA YOSHIYUKI (JP)
Application Number:
PCT/JP2015/086178
Publication Date:
June 30, 2016
Filing Date:
December 25, 2015
Export Citation:
Assignee:
DAIICHI SANKYO CO LTD (JP)
International Classes:
A61K31/444; A61K36/81; A61K45/00; A61P7/02; A61P43/00
Domestic Patent References:
| WO2008129846A1 | 2008-10-30 | |||
| WO2013039202A1 | 2013-03-21 | |||
| WO2011115065A1 | 2011-09-22 | |||
| WO2011115064A1 | 2011-09-22 |
Foreign References:
| JP2002322199A | 2002-11-08 |
Other References:
See also references of EP 3238721A4
Attorney, Agent or Firm:
ISHIBASHI, Koki et al. (JP)
Kimiki Ishibashi (JP)
Kimiki Ishibashi (JP)
Download PDF: